Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure

Circulation Research

Volumn 114, Issue 10, 2014, Pages 1569-1575

  Kumarswamy, Regalla ^a   Bauters, Christophe ^b,c,d   Volkmann, Ingo ^a   Maury, Fleur ^b,c   Fetisch, Jasmin ^a   Holzmann, Angelika ^a   Lemesle, Gilles ^b,c,d   De Groote, Pascal ^c,d   Pinet, Florence ^b,c,d   Thum, Thomas ^a,e  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIV LILLE   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Cardiac biomarkers; Cardiac remodeling; Circulating lncRNA; Heart failure; Mitochondria; Myocardial infarction; RNA, long noncoding

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LONG INTERGENIC NONCODING RNA PREDICTING CARDIAC REMODELING; LONG UNTRANSLATED RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DOWN REGULATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC RISK; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MITOCHONDRIAL GENOME; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL; TRANSCRIPTOMICS; UPREGULATION;

CARDIAC BIOMARKERS; CARDIAC REMODELING; CIRCULATING LNCRNA; HEART FAILURE; MITOCHONDRIA; MYOCARDIAL INFARCTION; RNA, LONG NONCODING;

ADULT; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RNA, LONG NONCODING; SURVIVAL RATE; VENTRICULAR REMODELING;

EID: 84900844231     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.114.303915     Document Type: Article

References (22)

1. Mandel P, Métais P. Les acides nucléiques du plasma sanguin chez l' homme. C R Acad Sci Paris. 1948;142:241-243
2. Kopreski MS, Benko FA, Kwak LW, Gocke CD. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res. 1999;5:1961-1965
3. Lo KW, Lo YM, Leung SF, Tsang YS, Chan LY, Johnson PJ, Hjelm NM, Lee JC, Huang DP. Analysis of cell-free epstein-barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clin Chem. 1999;45:1292-1294
4. Kung JT, Colognori D, Lee JT. Long noncoding RNAs: Past, present, and future. Genetics. 2013;193:651-669
5. Batista PJ, Chang HY. Long noncoding RNAs: Cellular address codes in development and disease. Cell. 2013;152:1298-1307
6. Reis EM, Verjovski-Almeida S. Perspectives of long non-coding RNAs in cancer diagnostics. Front Genet. 2012;3:32
7. De Kok JB, Verhaegh GW, Roelofs RW, Hessels D, Kiemeney LA, Aalders TW, Swinkels DW, Schalken JA. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res. 2002;62:2695-2698
8. Hessels D, Klein Gunnewiek JM, Van Oort I, Karthaus HF, Van Leenders GJ, Van Balken B, Kiemeney LA, Witjes JA, Schalken JA. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol. 2003;44:8-15; discussion 15
9. Du Z, Fei T, Verhaak RG, Su Z, Zhang Y, Brown M, Chen Y, Liu XS. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat Struct Mol Biol. 2013;20:908-913
10. Askarian-Amiri ME, Crawford J, French JD, Smart CE, Smith MA, Clark MB, Ru K, Mercer TR, Thompson ER, Lakhani SR, Vargas AC, Campbell IG, Brown MA, Dinger ME, Mattick JS. SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA. 2011;17:878-891
11. Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R, Kim S, Safe S. HOTAIR is a negative prognostic factor and exhibits pro- oncogenic activity in pancreatic cancer. Oncogene. 2013;32:1616-1625
12. Kumarswamy R, Thum T. Non-coding RNAs in cardiac remodeling and heart failure. Circ Res. 2013;113:676-689
13. Savoye C, Equine O, Tricot O, Nugue O, Segrestin B, Sautière K, Elkohen M, Pretorian EM, Taghipour K, Philias A, Aumégeat V, Decoulx E, Ennezat PV, Bauters C; REmodelage VEntriculaire Study Group. Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group). Am J Cardiol. 2006;98:1144-1149
14. St John Sutton M, Pfeffer MA, Plappert T, Rouleau JL, Moyé LA, Dagenais GR, Lamas GA, Klein M, Sussex B, Goldman S. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation. 1994;89:68-75
15. Fertin M, Hennache B, Hamon M, Ennezat PV, Biausque F, Elkohen M, Nugue O, Tricot O, Lamblin N, Pinet F, Bauters C. Usefulness of serial assessment of B-Type natriuretic peptide, troponin I, and C-reactive protein to predict left ventricular remodeling after acute myocardial infarction (from the REVE-2 study). Am J Cardiol. 2010;106:1410-1416
16. De Groote P, Dagorn J, Soudan B, Lamblin N, McFadden E, Bauters C. B-Type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol. 2004;43:1584-1589
17. De Groote P, Fertin M, Goéminne C, Petyt G, Peyrot S, Foucher-Hossein C, Mouquet F, Bauters C, Lamblin N. Right ventricular systolic function for risk stratification in patients with stable left ventricular systolic dysfunction: Comparison of radionuclide angiography to echoDoppler parameters. Eur Heart J. 2012;33:2672-2679
18. Hoyert D, Xu J. Deaths: Preliminary data for 2011. Natl Vital Stat Rep. 2012;61:1-65
19. Emdin M, Vittorini S, Passino C, Clerico A. Old and new biomarkers of heart failure. Eur J Heart Fail. 2009;11:331-335
20. Bussemakers MJ, Van Bokhoven A, Verhaegh GW, Smit FP, Karthaus HF, Schalken JA, Debruyne FM, Ru N, Isaacs WB. DD3: A new prostate- specific gene, highly overexpressed in prostate cancer. Cancer Res. 1999;59:5975-5979
21. Yang KC, Yamada KA, Patel AY, Topkara VK, George I, Cheema FH, Ewald GA, Mann DL, Nerbonne JM. Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support. Circulation. 2014;129:1009-1021
22. Huang X, Yuan T, Tschannen M, Sun Z, Jacob H, Du M, Liang M, Dittmar RL, Liu Y, Liang M, Kohli M, Thibodeau SN, Boardman L, Wang L. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics. 2013;14:319. doi:10.1186/1471-2164-14-319